AskNiveshClosed·16:51 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to GLAND

Gland Pharma Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
1,4251,5061,4871,6951,743
Other income
44588463111
Expenses
1,1811,2501,2871,3721,348
Cost of materials consumed
588557558530594
Purchases of stock-in-trade
30.90222
Change in inventories
-103-37-745-5
Employee benefit expense
373408385424412
Finance costs
8128410
Depreciation & amortisation
96101106108109
Other expenses
216209234260227
EBITDA
391426398474625
EBIT
296325292366516
Exceptional items
----24-
Profit Before Tax
288313284362506
Tax expense
10297100101139
Deferred tax
-2-5-4-8-5
Net Profit
187215184261367
Financial Ratios
Operating Profit Margin
20.74%21.55%19.62%21.59%29.60%
EBITDA Margin
27.46%28.25%26.75%27.96%35.86%
Net Profit Margin
13.12%14.28%12.37%15.40%21.06%
Earnings Per Share (₹)
11.3213.0811.1515.8722.26

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.